These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 33331525)

  • 61. Seroprevalence of IgG antibodies against SARS-CoV-2 among the general population and healthcare workers in India, June-July 2021: A population-based cross-sectional study.
    Murhekar MV; Bhatnagar T; Thangaraj JWV; Saravanakumar V; Santhosh Kumar M; Selvaraju S; Rade K; Kumar CPG; Sabarinathan R; Asthana S; Balachandar R; Bangar SD; Bansal AK; Bhat J; Chakraborty D; Chopra V; Das D; Devi KR; Dwivedi GR; Jain A; Khan SMS; Kumar MS; Laxmaiah A; Madhukar M; Mahapatra A; Ramesh T; Rangaraju C; Turuk J; Yadav S; Bhargava B;
    PLoS Med; 2021 Dec; 18(12):e1003877. PubMed ID: 34890407
    [TBL] [Abstract][Full Text] [Related]  

  • 62. SARS-CoV-2 seroprevalence in oncology healthcare professionals and patients with cancer at a tertiary care centre during the COVID-19 pandemic.
    Fuereder T; Berghoff AS; Heller G; Haslacher H; Perkmann T; Strassl R; Berger JM; Puhr HC; Kreminger J; Moik F; Schubert L; Starzer AM; Steindl A; Winkler S; Preusser M; Tobudic S
    ESMO Open; 2020 Sep; 5(5):e000889. PubMed ID: 32878898
    [TBL] [Abstract][Full Text] [Related]  

  • 63. SARS-CoV-2 herd immunity of the Kyrgyz population in 2021.
    Popova AY; Kasymov OT; Smolenski VY; Smirnov VS; Egorova SA; Nurmatov ZS; Milichkina AM; Suranbaeva GS; Kuchuk TE; Khamitova IV; Zueva EV; Ivanov VA; Nuridinova ZN; Derkenbaeva AA; Drobyshevskaya VG; Sattarova GZ; Kaliev MT; Gubanova AV; Zhimbaeva OB; Razumovskaya AP; Verbov VN; Likhachev IV; Krasnov AV; Totolian AA
    Med Microbiol Immunol; 2022 Aug; 211(4):195-210. PubMed ID: 35780233
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Serological investigation of asymptomatic cases of SARS-CoV-2 infection reveals weak and declining antibody responses.
    Yang Y; Wang X; Du RH; Zhang W; Si HR; Zhu Y; Shen XR; Li Q; Li B; Men D; Zhou YN; Wang H; Tong XL; Zhang XE; Shi ZL; Zhou P
    Emerg Microbes Infect; 2021 Dec; 10(1):905-912. PubMed ID: 33870851
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Prevalence of SARS-CoV-2 IgG antibodies in an area of northeastern Italy with a high incidence of COVID-19 cases: a population-based study.
    Stefanelli P; Bella A; Fedele G; Pancheri S; Leone P; Vacca P; Neri A; Carannante A; Fazio C; Benedetti E; Fiore S; Fabiani C; Simmaco M; Santino I; Zuccali MG; Bizzarri G; Magnoni R; Benetollo PP; Merler S; Brusaferro S; Rezza G; Ferro A
    Clin Microbiol Infect; 2021 Apr; 27(4):633.e1-633.e7. PubMed ID: 33253941
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Population-based surveys of antibodies against SARS-CoV-2 in Southern Brazil.
    Silveira MF; Barros AJD; Horta BL; Pellanda LC; Victora GD; Dellagostin OA; Struchiner CJ; Burattini MN; Valim ARM; Berlezi EM; Mesa JM; Ikeda MLR; Mesenburg MA; Mantesso M; Dall'Agnol MM; Bittencourt RA; Hartwig FP; Menezes AMB; Barros FC; Hallal PC; Victora CG
    Nat Med; 2020 Aug; 26(8):1196-1199. PubMed ID: 32641783
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Estimation of SARS-CoV-2 Infection Fatality Rate by Real-time Antibody Screening of Blood Donors.
    Erikstrup C; Hother CE; Pedersen OBV; Mølbak K; Skov RL; Holm DK; Sækmose SG; Nilsson AC; Brooks PT; Boldsen JK; Mikkelsen C; Gybel-Brask M; Sørensen E; Dinh KM; Mikkelsen S; Møller BK; Haunstrup T; Harritshøj L; Jensen BA; Hjalgrim H; Lillevang ST; Ullum H
    Clin Infect Dis; 2021 Jan; 72(2):249-253. PubMed ID: 33501969
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Seroprevalence of Antibodies Specific to Receptor Binding Domain of SARS-CoV-2 and Vaccination Coverage Among Adults in Los Angeles County, April 2021: The LA Pandemic Surveillance Cohort Study.
    Sood N; Pernet O; Lam CN; Klipp A; Kotha R; Kovacs A; Hu H
    JAMA Netw Open; 2022 Jan; 5(1):e2144258. PubMed ID: 35050360
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Seroprevalence of anti-SARS-CoV-2 antibodies and factors associated with infection among adolescent men who have sex with men and transgender women in Salvador, Brazil.
    Santos CC; de M Lima FW; Magno L; Soares F; Ferraz D; Grangeiro A; Zucchi EM; Préau M; Mabire X; Matos HRSS; Dourado I;
    BMC Public Health; 2023 Jan; 23(1):61. PubMed ID: 36624484
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Sentinel seroprevalence of SARS-CoV-2 in Gauteng Province, South Africa, August - October 2020.
    George JA; Khoza S; Mayne E; Dlamini S; Kone N; Jassat W; Chetty K; Centner CM; Pillay T; Maphayi M; Mabuza D; Maposa I; Cassim N
    S Afr Med J; 2021 Nov; 111(11):1078-1083. PubMed ID: 34949273
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Seroprevalence and levels of IgG antibodies after COVID-19 infection or vaccination.
    Soeorg H; Jõgi P; Naaber P; Ottas A; Toompere K; Lutsar I
    Infect Dis (Lond); 2022 Jan; 54(1):63-71. PubMed ID: 34520315
    [TBL] [Abstract][Full Text] [Related]  

  • 72. SARS-CoV-2 seroprevalence in the city of Puerto Madryn: Underdiagnosis and relevance of children in the pandemic.
    Schonfeld D; Fernández H; Ramírez J; Acosta D; Becerra J; Wettstein M; Strella T; Vaccaro M; Arias S; Rodríguez Calvo V; Neme R; Pérez-Chada D
    PLoS One; 2022; 17(3):e0263679. PubMed ID: 35286328
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Seroprevalence of anti-SARS-CoV-2 antibodies after the first wave of the COVID-19 pandemic in a vulnerable population in France: a cross-sectional study.
    Beaumont A; Durand C; Ledrans M; Schwoebel V; Noel H; Le Strat Y; Diulius D; Colombain L; Médus M; Gueudet P; Mouly D; Aumaître H
    BMJ Open; 2021 Nov; 11(11):e053201. PubMed ID: 34815286
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Seroprevalence Surveys for Anti-SARS-CoV-2 Antibody in Different Populations in Taiwan With Low Incidence of COVID-19 in 2020 and Severe Outbreaks of SARS in 2003.
    Tseng WP; Wu JL; Wu CC; Kuo KT; Lin CH; Chung MY; Lee YF; Yang BJ; Huang CH; Chen SY; Yu CJ; Chen SC; Hsueh PR
    Front Immunol; 2021; 12():626609. PubMed ID: 34084161
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Estimated SARS-CoV-2 Seroprevalence in US Patients Receiving Dialysis 1 Year After the Beginning of the COVID-19 Pandemic.
    Anand S; Montez-Rath M; Han J; Cadden L; Hunsader P; Kerschmann R; Beyer P; Boyd SD; Garcia P; Dittrich M; Block GA; Parsonnet J; Chertow GM
    JAMA Netw Open; 2021 Jul; 4(7):e2116572. PubMed ID: 34251441
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Community-Based Seroprevalence of SARS-CoV-2 Antibodies following the First Wave of the COVID-19 Pandemic in Jazan Province, Saudi Arabia.
    Alhazmi A; Alamer E; Abdelwahab S; Khamjan N; Hamami A; Haddad M; Darraj M; Hashem AM; Algaissi A
    Int J Environ Res Public Health; 2021 Nov; 18(23):. PubMed ID: 34886175
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Seroprevalence of SARS-CoV-2-specific antibodies in cancer outpatients in Madrid (Spain): A single center, prospective, cohort study and a review of available data.
    Cabezón-Gutiérrez L; Custodio-Cabello S; Palka-Kotlowska M; Oliveros-Acebes E; García-Navarro MJ; Khosravi-Shahi P
    Cancer Treat Rev; 2020 Nov; 90():102102. PubMed ID: 32947121
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Seroprevalence and factors associated with SARS-CoV-2 infection among education workers after the first wave: the first cross-sectional study in Brazil.
    França PC; Silva PGB; Rocha JLC; Perdigão ACB; Oliveira NS; Araújo FMC; Fonseca MHG; Lima GRP; Almeida MM; Alencar CH; Oliveira WK; Cavalcanti LPG
    Rev Soc Bras Med Trop; 2022; 55():e06062021. PubMed ID: 35522813
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Seroprevalence of SARS-CoV-2-Specific IgG Antibodies Among Adults Living in Connecticut: Post-Infection Prevalence (PIP) Study.
    Mahajan S; Srinivasan R; Redlich CA; Huston SK; Anastasio KM; Cashman L; Massey DS; Dugan A; Witters D; Marlar J; Li SX; Lin Z; Hodge D; Chattopadhyay M; Adams MD; Lee C; Rao LV; Stewart C; Kuppusamy K; Ko AI; Krumholz HM
    Am J Med; 2021 Apr; 134(4):526-534.e11. PubMed ID: 33130124
    [TBL] [Abstract][Full Text] [Related]  

  • 80. A cross-sectional investigation of SARS-CoV-2 seroprevalence and associated risk factors in children and adolescents in the United States.
    Levorson RE; Christian E; Hunter B; Sayal J; Sun J; Bruce SA; Garofalo S; Southerland M; Ho S; Levy S; Defillipi C; Peake L; Place FC; Hourigan SK
    PLoS One; 2021; 16(11):e0259823. PubMed ID: 34748615
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.